Aortic Valve Replacement Devices Market Report | 2022-2030

Aortic Valve Replacement Devices Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Sutureless Valve and Mechanical Valve), Surgery (Minimally Invasive Surgery and Open Surgery), End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Others), and Geography

Publication Month : Aug 2023

  • Report Code : TIPRE00002871
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 165
Inquire Before Buy

PRICING

$4550

$3640

[Research Report] The aortic valve replacement devices market was valued at US$ 7,113.39 million in 2022 and is expected to reach US$ 18,070.32 million by 2030. It is estimated to register a CAGR of 12.4% during 2022–2030.  

Analyst’s Viewpoint

The aortic valve replacement devices market analysis explains driving factors such as a rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques. Further, the increasing number of clinical studies acts as a future trend for the market growth during 2022–2030. The sutureless valve segment accounted for a larger share of the aortic valve replacement devices market, based on product, in 2022. In terms of surgery, the minimally invasive surgery segment dominated the market in 2022. By end user, the hospitals & clinics segment would dominate the aortic valve replacement devices market with a considerable share during the forecast period.

Aortic valve is one of four valves that regulate blood flow through the heart. The aortic valve separates the heart's main pumping chamber and the main artery that supplies oxygen-rich blood to the body. Aortic valve repair or aortic valve replacement treats aortic valve disease and help restore normal blood flow, reduces symptom, prolong life, and help preserve the function of the heart muscle.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Aortic Valve Replacement Devices Market: Strategic Insights

aortic-valve-replacement-devices-market
Market Size Value inUS$ 7,113.39 million in 2022
Market Size Value byUS$ 18,070.32 million by 2030
Growth rateCAGR of 12.4% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Market Insights

Rising Number of Aortic Valve Replacement Surgeries Boosts Aortic Valve Replacement Devices Market Growth

There has been a significant increase in the number of aortic valve replacement surgeries performed worldwide recently. According to data published by The Texas Herat Institute, ~106,000 heart valve procedures are performed annually in the US. The mitral or aortic valves are repaired or replaced in almost all of these procedures. This surge can be attributed to several factors, including advancements in medical technology, an aging population, and improved awareness of heart-related conditions. Aortic valve replacement is a critical procedure often performed to treat aortic valve stenosis or regurgitation—conditions that can lead to serious complications if left untreated. As medical science continues to evolve, these surgeries are expected to become even safer and more accessible, contributing to better patient outcomes and improved quality of life for those affected by aortic valve diseases. Healthcare systems are adapting to accommodate this growing demand for surgical interventions, emphasizing the importance of preventive measures and early detection in managing cardiovascular health.

Technological Advancements are Creating Lucrative Opportunities in Aortic Valve Replacement Devices Market

The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.

A few technological advancements by the players in the aortic valve replacement devices are mentioned below:

  • In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company's extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.
  • In September 2022, Medtronic announced the expansion of its newest-generation, self-expanding TAVR system—the Evolut FX TAVR system—in the US. Evolut FX added new features to the existing Evolut platform to enhance the ease of use and predictable valve deployment for physicians.
  • In September 2022, Edwards Lifesciences launched SAPIEN 3 Ultra RESILIA valve, which includes Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve. The launch follows recent US Food and Drug Administration (FDA) approval.
  • In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.
  • In August 2021, CORCYM enrolled the first patient in the mitral, aortic, and tricuspid post-market study in a real-world setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve.
  • In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves.
  • In September 2020, Boston Scientific Corporation introduced the ACURATE neo2 aortic valve system in Europe. This next-generation TAVI technology—a new platform designed with multiple features to improve the clinical performance of the original ACURATE neo platform—had an expanded indication for patients with aortic stenosis compared to the aortic valve system of the previous generation.

Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.

Report Segmentation and Scope

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Product-Based Insights

Based on product, the aortic valve replacement devices market is bifurcated into mechanical valve and sutureless valve. The sutureless valve segment held a larger market share in 2022 and is likely to register a significant CAGR in the aortic valve replacement devices market during 2022–2030. A sutureless aortic valve replacement device is a bioprosthetic valve designed for implementation without the need for traditional suturing, which is required to secure the valve in a position. These valves are typically made from biological materials. The valve is attached to a stent or frame that can expand and secure it in place once it is positioned correctly within the patient's native aortic valve annulus. The main advantage of sutureless aortic valves is that they can simplify the surgical procedure, reducing surgical time and potentially improving outcomes, especially in patients at higher risk or having limited surgical access due to other medical conditions. As with any medical procedure, the choice of aortic valve replacement device, including sutureless valves, depends on the patient's specific condition, overall health, and individual risk factors.

Surgery-Based Insights

Based on surgery, the aortic valve replacement devices market is bifurcated into open surgery and minimally invasive surgery. The minimally invasive surgery segment accounted for a larger market share in 2022 and is expected to register a higher CAGR during 2022–2030. Minimally invasive surgery for aortic valve replacement is a less invasive approach compared to traditional open surgery. It involves making smaller incisions, often using specialized surgical instruments and video-assisted technology, to access the heart to replace a poorly working aortic valve with an artificial valve, either a mechanical valve or a bioprosthetic valve. The potential benefits of minimally invasive techniques include shorter hospital stays, reduced scarring, and faster recovery times (in normal conditions). TAVR operations are chosen in most cases because they cause less tissue damage and are followed by a quicker recovery time. According to the New England Journal of Medicine, since the inception of this technique in 2007, the number of TAVR surgeries has significantly increased, as surgical replacement has proven unsuitable for older patients. As medical technology advances, these minimally invasive approaches offer more options and improved outcomes for patients requiring aortic valve replacement.

End User-Based Insights

In terms of end user, the aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment accounted for the largest market share in 2022. Hospitals & clinics are the largest end users of aortic valve replacement devices, which can be used for treating patients from different age groups suffering from various medical conditions. Many patients visit hospitals to seek treatments for their acute and chronic conditions. Medical staff at hospitals offer convenient services and the best care to patients. Thus, hospitals aim to restore and maintain the public's good health. Staff members employed in hospitals are aware of different aortic valve replacement devices. The rising prevalence of chronic diseases, growing geriatric population, and increasing number of hospitals primarily contribute to the growth of the aortic valve replacement market for the hospitals segment. The geriatric population is twice as likely to get hospitalized than adults of middle age; approximately 17% of Americans aged 65 and above get hospitalized at least once a year, while only 8% of adults aged 45–64 require hospitalization. Cardiovascular disorders, cancer, stroke, and neurological diseases are the leading causes of hospitalization among older patients. Thus, the higher number of patients getting admitted to hospitals is likely to boost the growth of the market for the hospital segment during the forecast period.

Well-being

platforms Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis

North America dominated the aortic valve replacement devices market in 2022 accounting for a maximum share, with the US, Canada, and Mexico being the major contributors to the regional market growth. The US is the largest market for aortic valve replacement devices in this region. The aortic valve replacement devices market growth in North America is attributed to the rising prevalence of heart diseases and increasing number of regulatory approvals, R&D activities, and new product launches. Additionally, the technological advancement in the product is likely to offer growth opportunities to the aortic valve replacement devices market in the region.

According to the Cleveland Clinic, heart valve disease affects ~2.5% of people in the US. These include valve regurgitation (leaky) or stenosis (narrowing). Mitral regurgitation and aortic stenosis are the most common valvular diseases in the US. More than 2 million people in the US suffer from a leaking heart valve. The US is at the forefront of the North America aortic valve replacement devices market. Nearly 1.5 million people suffer from aortic stenosis in the US. According to the data published by the National Institutes of Health (NIH), in 2021, ~78,000 transcatheter aortic valve implantation (TAVI) surgeries were performed annually in the country. The presence of key players and the increasing number of clinical studies in the region drive market growth. Initiatives undertaken by private institutions are also expected to bolster the growth of the market. For instance, Edwards Lifesciences Foundation is sponsoring the American Heart Association’s Valvular Disease Education Center and Ambassador Program in the US. Thus, the abovementioned factors are expected to fuel the market growth in the US.

The report profiles leading players operating in the global aortic valve replacement devices market. These include Virgin Pulse Inc, Limeade Inc, Optum Inc, Vitality Group International Inc, Bravo Wellness LLC, Sonic Boom Wellness LLC, WebMD Health Services Group Inc, Fitbit LLC, Asset Health Inc, Healthcheck360, Marquee Health LLC, Wellright Inc, Wellworks for You, Wellable LLC, Wellness 360 Technologies Inc, WellSteps.com LLC, and CHC Wellbeing Inc.

  • In February 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).
  • In January 2023, Abbott received the US Food and Drug Administration (FDA) approval for the company's latest generation transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis at high or extreme risk for open-heart surgery. The Navitor TAVI system is the latest addition to the company's comprehensive transcatheter structural heart portfolio that offers less invasive treatment options to physicians and patients for some of the most common and serious heart diseases.
  • In July 2021, Limeade acquired TINYPULSE, a pioneer in employee listening software. The acquisition will unite two companies committed to helping their customers create healthy employee experiences.
  • In November 2021, Virgin Pulse acquired Welltok to drive better health outcomes and cost reductions. The acquisition would allow the two companies to introduce the industry's first end-to-end engagement and activation platform, supporting clients, members, and consumers across the entire health community.

Company Profiles

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • LivaNova Plc
  • Edwards Lifesciences Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Artivion Inc
  • JenaValve Technology Inc
  • Venus MedTech HangZhou Inc
  • Labcor Laboratorios Ltda
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Surgery, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the aortic valve replacement devices market?

The factors driving the growth of the aortic valve replacement devices market include the rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques. However, the product recalls of aortic valve replacement devices hampers the growth of the aortic valve replacement devices market.

Who are the major players in the aortic valve replacement devices market?

The aortic valve replacement devices market majorly consists of the following players, Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, JenaValve Technology Inc, Venus MedTech HangZhou Inc, and Labcor Laboratorios Ltda.

Which segment is dominating the aortic valve replacement devices market?

Based on product, the aortic valve replacement devices market is bifurcated into mechanical valve and sutureless valve. The sutureless valve segment held the larger market share in 2022 and the same segment registered a significant CAGR in the aortic valve replacement devices market in 2022-2030.

What was the estimated aortic valve replacement devices market size in 2022?

The aortic valve replacement devices market was valued at US$ 7,113.39 billion in 2022.

What are the growth estimates for the aortic valve replacement devices market till 2030?

The aortic valve replacement devices market is expected to be valued at US$ 18,070.32 billion in 2030.

What is aortic valve replacement devices?

Aortic valve repair and aortic valve replacement are methods that treat diseases affecting the aortic valve. The aortic valve is one of four valves that regulate blood flow through the heart. The aortic valve separates the heart's main pumping chamber and the main artery that supplies oxygen-rich blood to body. Aortic valve repair or aortic valve replacement treats aortic valve disease and help restore normal blood flow, reduces symptom, prolong life and help preserves the function of the heart muscle.

The List of Companies - Aortic Valve Replacement Devices Market

  1. Abbott Laboratories
  2. Medtronic Plc
  3. Boston Scientific Corp
  4. LivaNova Plc
  5. Edwards Lifesciences Corp
  6. Braile Biomedica Industry, Commerce and Representations Ltd
  7. Artivion Inc
  8. JenaValve Technology Inc.
  9. Venus MedTech HangZhou Inc.
  10. Labcor Laboratorios Ltda

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Aortic Valve Replacement Devices Market